Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 597,395 | 394,796 | 551,192 | 286,668 | 264,126 |
| Marketable Securities | N/A | N/A | N/A | 231,446 | N/A |
| Receivables | 49,166 | 3,094 | 2,753 | 9,090 | 156 |
| Other current assets | 67,708 | 40,247 | 15,869 | 7,514 | 2,155 |
| TOTAL | $714,269 | $438,137 | $569,814 | $534,718 | $266,437 |
| Non-Current Assets | |||||
| PPE Net | 141,063 | 86,510 | 88,192 | 64,725 | 25,967 |
| Intangibles | 484,728 | 88,499 | 2,107 | 2,186 | 2,490 |
| Other Non-Current Assets | 108,538 | 40,553 | 41,175 | 8,716 | 3,691 |
| TOTAL | $734,329 | $215,562 | $131,474 | $75,627 | $32,148 |
| Total Assets | $1,448,598 | $653,699 | $701,288 | $610,345 | $298,585 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,613 | 3,953 | 4,586 | 2,819 | 1,074 |
| Accrued Expenses | 81,872 | 46,635 | 32,904 | 32,333 | 10,485 |
| Other current liabilities | 61,767 | 36,426 | 56,726 | 10,000 | 10,000 |
| TOTAL | $187,472 | $93,171 | $100,265 | $46,658 | $23,099 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,022 | 1,101 | 536 | 633 | 11,414 |
| Other Non-Current Liabilities | 190,747 | 94,652 | 114,681 | 16,006 | 19,375 |
| TOTAL | $226,344 | $97,092 | $115,217 | $20,749 | $33,463 |
| Total Liabilities | $413,816 | $190,263 | $215,482 | $67,407 | $56,562 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 401,991 | 234,653 | 191,233 | 170,774 | N/A |
| Common Shares | 4 | 2 | 2 | 2 | N/A |
| Retained earnings | -1,431,283 | -967,622 | -639,556 | -400,080 | -213,601 |
| Other shareholders' equity | -7,637 | 0 | 0 | -126 | 448,312 |
| TOTAL | $1,034,782 | $463,436 | $485,806 | $542,938 | $242,023 |
| Total Liabilities And Equity | $1,448,598 | $653,699 | $701,288 | $610,345 | $298,585 |